LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

Upregulation of LncRNA71132 in spinal cord regulates hypersensitivity in rat model of bone cancer pain.

Photo from wikipedia

ABSTRACT Bone cancer pain (BCP) is a pervasive clinical symptom which impairs the quality life. Long non-coding RNAs (lncRNAs) are enriched in the central nervous system (CNS) and play indispensable… Click to show full abstract

ABSTRACT Bone cancer pain (BCP) is a pervasive clinical symptom which impairs the quality life. Long non-coding RNAs (lncRNAs) are enriched in the central nervous system (CNS) and play indispensable roles in numerous biological processes, while its regulatory function in nociceptive information processing remains elusive. Here, we reported that functional modulatory role of ENSRNOT00000071132 (lncRNA71132) in the BCP process and sponging with miR-143 and its downstream GPR85-dependent signaling cascade. Spinal lncRNA71132 was remarkably increased in the rat model of bone cancer pain. The knockdown of spinal lncRNA71132 reverted BCP behaviors and spinal c-Fos neuronal sensitization. Over-expression of spinal lncRNA71132 in naive rat generated pain behaviors, which were accompanied by increased spinal c-Fos neuronal sensitization. Furthermore, it was found that lncRNA71132 participates in the modulation of BCP by inversely regulating the processing of miR-143-5p. In addition, an increase in expression of spinal lncRNA71132 resulted in the decrease in expression of miR-143 under BCP state. Finally, it was found that miR-143-5p regulates pain behaviors by targeting GPR85. Over-expression of miR-143-5p in the spinal cord reverted the nociceptive behaviors triggered by BCP, accompanied by a decrease in expression of spinal GPR85 protein, but no influence on expression of gpr85 mRNA. The findings of the present study indicate that lncRNA71132 works as a miRNA sponge in miR-143-5p mediated post-transcriptional modulation of GPR85 expression in BCP. Therefore, epigenetic interventions against lncRNA71132 may potentially work as novel treatment avenues in treating nociceptive hypersensitivity triggered by bone cancer.

Keywords: cancer pain; bone cancer; mir 143; expression

Journal Title: Pain
Year Published: 2022

Link to full text (if available)


Share on Social Media:                               Sign Up to like & get
recommendations!

Related content

More Information              News              Social Media              Video              Recommended



                Click one of the above tabs to view related content.